NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT00562380 2013-07-18AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed64 enrolled